FDA Archives - Page 6 of 25

A Colorful Cast Could Lead Key Health Agencies

Episode 375

Dec. 5, 2024

President-elect Donald Trump has made his choices to fill some top jobs at the Department of Health and Human Services. They include controversial figures who were vocal critics of the Biden administration’s handling of the covid pandemic and have proposed sweeping changes to the agencies they would lead. Meanwhile, the Supreme Court heard its first two health-related cases of the term, challenging a Tennessee law barring transgender medical care for minors and, separately, challenging the FDA’s handling of e-cigarettes. Joanne Kenen of the Johns Hopkins University and Politico, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join �Թϲ��’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews �Թϲ��’ Bram Sable-Smith, who reported and wrote the latest �Թϲ��-Washington Post Well+Being “Bill of the Month” feature, about an emergency room bill for a visit that didn’t get past the waiting room.

Listen Now

A photo of Donald Trump with Robert F. Kennedy, Jr.

Make America Healthy Again: An Unconventional Movement That May Have Found Its Moment

Nonmainstream doctors and leaders in health business are wielding serious muscle in shaping the incoming Trump administration’s health policies and challenging prevailing thinking on public health, disease prevention, and chronic illness.

By Stephanie Armour

Nov. 26, 2024

A photo of Ron DeSantis speaking inside a warehouse at a podium with a sign that reads, "Lower drug costs."

Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval

Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.

By Phil Galewitz

Nov. 21, 2024

A still from a broadcast of Céline Gounder on CBS News and a still image of President-elect Donald Trump shaking hands with Robert F. Kennedy Jr. The chyron reads "Dr. Gounder on RFK Jr. pick and potential impact."

What To Know About RFK Jr.’s Stances on Key Health Issues and What He Could Do at HHS

By Céline Gounder

Nov. 15, 2024

A photo of Robert F. Kennedy, Jr. speaking at a podium.

Scientists Fear What’s Next for Public Health if RFK Jr. Is Allowed To ‘Go Wild’

As federal health scientists await a potential takeover by RFK Jr. and other medical skeptics in the second Trump administration, some are preparing résumés or retirement papers.

By Arthur Allen

Nov. 14, 2024

�Թϲ�� & PolitiFact HealthCheck

No Evidence Trump’s Drug Program for Terminal Patients Saved ‘Thousands’ of Lives

Though the former president has repeatedly hyped the impact of his experimental drug program, there’s no basis for his claims in government data, and medical experts say he’s exaggerating.

By Jacob Gardenswartz

Nov. 4, 2024

A digital illustration of a hand putting a piece on paper into a ballet box. The box has a Rod of Asclepius on it, signifying the topic of health.

What’s at Stake: A Pivotal Election for Six Big Health Issues

Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.

By Arthur Allen, Phil Galewitz, Julie Rovner, and Daniel Chang

Nov. 1, 2024

What the Health? From �Թϲ��

Less Than Two Weeks To Go

Episode 369

Oct. 24, 2024

With Election Day rapidly approaching, abortion is gaining traction as a voting issue, according to public opinion polls. Meanwhile, states with abortion bans are reviving the lawsuit — dismissed by the Supreme Court on a technicality this year — that could roll back the availability of the abortion pill mifepristone. Sarah Karlin-Smith of the Pink Sheet, Rachel Cohrs Zhang of Stat, and Victoria Knight of Axios join �Թϲ��’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Tricia Neuman, senior vice president of KFF and executive director of its Program on Medicare Policy, about Medicare open enrollment and the changes to the federal program for 2025.

Listen Now

An illustration of a white mug with an orange poppy flower decoration on the side. Steam is wafting from the tea in the mug.

Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention of Lawmakers

Poppy seeds contaminated with opioids can be used to make a deadly brew, a watchdog says.

By David Hilzenrath

Oct. 9, 2024

Systemic Sickness

FDA’s Promised Guidance on Pulse Oximeters Unlikely To End Decades of Racial Bias

For decades, the pulse oximeters used in hospitals, ambulances, and homes have underestimated the oxygen needs of darker-skinned patients. The FDA is preparing guidelines to fix that. But will the new rules go far enough?

By Arthur Allen

Oct. 7, 2024

Setting the Record Straight on the FDA’s Authority Over Drug Ads

�Թϲ�� gives readers a chance to comment on a recent batch of stories.

Oct. 2, 2024

Health Brief

Unpacking the FDA’s Non-Recall Recalls

By David Hilzenrath

Sept. 18, 2024

A hand is holding a remote control, there is a blurred TV screen in the background.

Perspective

With TV Drug Ads, What You See Is Not Necessarily What You Get

The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.

By Elisabeth Rosenthal

Sept. 9, 2024

�Թϲ�� On Air

Journalists Discuss African Mpox Upsurge, EpiPen Alternative, and Medicaid Unwinding

�Թϲ�� and California Healthline staff made the rounds on national and state media this week to discuss topical stories. Here’s a collection of their appearances.

Aug. 17, 2024

The FDA Calls Them ‘Recalls,’ Yet the Targeted Medical Devices Often Remain in Use

With medical devices, recalls are not always what they seem. In some recalls, including some of the most serious, the FDA and the manufacturers let doctors and hospitals continue to use the devices.

By David Hilzenrath

Aug. 15, 2024

Inside Project 2025: Former Trump Official Outlines Hard Right Turn Against Abortion

Former President Donald Trump has distanced himself from a Heritage Foundation document that outlines positions on abortion and a range of other social issues. But Democrats view it as a window into the far right’s to-do list and a clear opening for political attack.

By Stephanie Armour

Aug. 6, 2024

A close-up view of the sign for the U.S. Centers for Disease Control and Prevention in Atlanta. The white text on the blue background reads "Department of Health & Human Services USA"

The CDC’s Test for Bird Flu Works, but It Has Issues

The Centers for Disease Control and Prevention promises better tests are being developed, but the episode points to vulnerabilities in the country’s defense against emerging outbreaks.

By Arthur Allen and Amy Maxmen

July 26, 2024

An illustration drawn with pencil and colored digitally shows a scientist-type man in the center of the image. He holds two halves of an Ozempic-like injector in his gloved hands and pours a mysterious liquid from one side to the other. Behind him, corporate copycats, drawn as floating heads and hands, watch to steal his formula while they manipulate their own mysterious liquid. The floating copycats repeat into the background.

Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs

Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.

By Arthur Allen

July 23, 2024

A photo of Mehmet Oz standing at a podium, waving to a crowd.

When Medical Devices Malfunction

From Dr. Oz to Heart Valves: A Tiny Device Charted a Contentious Path Through the FDA

The story of MitraClip, a device Dr. Oz helped invent to treat faulty heart valves, is a cautionary tale about the science, business, and regulation of medical technology.

By David Hilzenrath and Holly K. Hacker

July 9, 2024

What the Health? From �Թϲ��

SCOTUS Term Wraps With a Bang

Episode 354

July 3, 2024

The Supreme Court has issued its final opinions for the 2023-24 term, including decisions affecting abortion access, the opioid epidemic, and how the federal government functions. In this special episode, Sarah Somers , legal director of the National Health Law Program, joins �Թϲ��’ chief Washington correspondent, Julie Rovner, to discuss how the justices disposed of the term’s health-related cases and what those decisions could mean going forward.

Listen Now

�Թϲ��

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

FDA